ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Viromed acquires US-based DNA Production Facility
biospectrumasia
October 15, 2018The facility in San Diego is equipped with a 500 L fermenter, cell culture lab and QC test lab, and has extra space for future expansion, making it an ideal site for both biopharmaceutical R&D and commercial-scale plasmid DNA production -
ViroMed Secures DNA Production Facility in the U.S.
contractpharma
August 22, 2018ViroMed?has acquired a plasmid DNA production facility in San Diego, CA from Vical Incorporated. With ViroMed's first Phase III clinical trial of its lead product VM202 (donaperminogene seltoplasmid) for painful diabetic peripheral neuropathy (PDPN) neari -
ViroMed Secures DNA Production Facility in the US
americanpharmaceuticalreview
August 21, 2018ViroMed announced the acquisition of a plasmid DNA production facility in San Diego, California from Vical Incorporated. With ViroMed's first Phase III clinical trial of its lead product VM202 (donaperminogene seltoplasmid) for painful diabetic peripheral
Pharma Sources Insight January 2025
